THE ROLE OF ARTIFICIAL INTELLIGENCE IN MODERN UROLOGY: A SYSTEMATIC OVERVIEW
DOI:
https://doi.org/10.31435/ijitss.4(48).2025.4330Keywords:
urology, Artificial Intelligence, Machine Learning, Prostatic Neoplasms, Diagnostic Imaging, Clinical Decision-MakingAbstract
Introduction and Purpose: Artificial intelligence (AI) is a revolutionary tool assisting diagnostics treatment, and prognosis of treatment outcomes in various medical fields, including urology. The purpose of this review is to outline contemporary uses of AI techniques in clinical urology and evaluate their effect on the quality of patient care, considering limitations and future research directions.
State of Knowledge: AI uses in urology consist of, inter alia, evaluation of radiological and histopathological images (for example, in prostate cancer diagnosis), treatment prediction outcomes (e.g., bladder cancer), individualization of treatment, improvement in surgical planning decisions and assistance in perioperative care. Machine learning algorithms are applied to recognize pathological changes with high accuracy, often like the assessments of experts. Natural language processing (NLP) algorithms are utilized in the analysis of medical documentation and streamlining information flow. Despite quick development, complete integration of AI into daily clinical practice faces barriers related to data quality, model interpretability, and legal and ethical aspects.
Summary: Artificial intelligence has excellent potential for enhancing diagnostic and therapeutic accuracy in urology. Nonetheless, additional clinical research, standardization and validation with multi-center datasets are required. The appropriate implementation of AI in urological practice can lead to personalized, more efficient patient management.
References
Basubrin O. Current Status and Future of Artificial Intelligence in Medicine. Cureus. 2025 Jan 16;17(1):e77561. http://doi:10.7759/cureus.77561. PMID: 39958114; PMCID: PMC11830112.
Thomas LB, Mastorides SM, Viswanadhan NA, Jakey CE, Borkowski AA. Artificial Intelligence: Review of Current and Future Applications in Medicine. Fed Pract. 2021 Nov;38(11):527-538. http://doi:10.12788/fp.0174. PMID: 35136337; PMCID: PMC8815615.
Hameed BMZ, S Dhavileswarapu AVL, Raza SZ, Karimi H, Khanuja HS, Shetty DK, Ibrahim S, Shah MJ, Naik N, Paul R, Rai BP, Somani BK. Artificial Intelligence and Its Impact on Urological Diseases and Management: A Comprehensive Review of the Literature. J Clin Med. 2021 Apr 26;10(9):1864. http://doi:10.3390/jcm10091864. PMID: 33925767; PMCID: PMC8123407.
Chen, J., Remulla, D., Nguyen, J.H., Dua, A., Liu, Y., Dasgupta, P. and Hung, A.J. (2019), Current status of artificial intelligence applications in urology and their potential to influence clinical practice. BJU Int, 124: 567-577. https://doi.org/10.1111/bju.14852
Hameed BMZ, S Dhavileswarapu AVL, Raza SZ, Karimi H, Khanuja HS, Shetty DK, Ibrahim S, Shah MJ, Naik N, Paul R, Rai BP, Somani BK. Artificial Intelligence and Its Impact on Urological Diseases and Management: A Comprehensive Review of the Literature. J Clin Med. 2021 Apr 26;10(9):1864. http://doi:10.3390/jcm10091864. PMID: 33925767; PMCID: PMC8123407.
Chowdhury AT, Salam A, Naznine M, Abdalla D, Erdman L, Chowdhury MEH, Abbas TO. Artificial Intelligence Tools in Pediatric Urology: A Comprehensive Review of Recent Advances. Diagnostics (Basel). 2024 Sep 17;14(18):2059. http://doi: 10.3390/diagnostics14182059. PMID: 39335738; PMCID: PMC11431426.
Shah M, Naik N, Somani BK, Hameed BMZ. Artificial intelligence (AI) in urology-Current use and future directions: An iTRUE study. Turk J Urol. 2020 Nov;46(Supp. 1):S27-S39. http://doi:10.5152/tud.2020.20117. Epub 2020 May 27. PMID: 32479253; PMCID: PMC7731952.
Cai JC, Nakai H, Kuanar S, Froemming AT, Bolan CW, Kawashima A, Takahashi H, Mynderse LA, Dora CD, Humphreys MR, Korfiatis P, Rouzrokh P, Bratt AK, Conte GM, Erickson BJ, Takahashi N. Fully Automated Deep Learning Model to Detect Clinically Significant Prostate Cancer at MRI. Radiology. 2024 Aug;312(2):e232635. http://doi: 10.1148/radiol.232635. PMID: 39105640; PMCID: PMC11366675.
He M, Cao Y, Chi C, Yang X, Ramin R, Wang S, Yang G, Mukhtorov O, Zhang L, Kazantsev A, Enikeev M, Hu K. Research progress on deep learning in magnetic resonance imaging-based diagnosis and treatment of prostate cancer: a review on thecurrent status and perspectives. Front Oncol. 2023 Jun 13;13:1189370. http://doi: 10.3389/fonc.2023.1189370. PMID: 37546423; PMCID: PMC10400334.
Lee YJ, Moon HW, Choi MH, Eun Jung S, Park YH, Lee JY, Kim DH, Eun Rha S, Kim SH, Lee KW, Choi YJ, Lee YS, Lee W, Lee S, Grimm R, von Busch H, Han D, Lou B, Kamen A. MRI-based Deep Learning Algorithm for Assisting Clinically Significant Prostate Cancer Detection: A Bicenter Prospective Study. Radiology. 2025 Mar;314(3):e232788. http://doi:10.1148/radiol.232788. PMID: 40067105.
Hamm CA, Baumgärtner GL, Biessmann F, Beetz NL, Hartenstein A, Savic LJ, Froböse K, Dräger F, Schallenberg S, Rudolph M, Baur ADJ, Hamm B, Haas M, Hofbauer S, Cash H, Penzkofer T. Interactive Explainable Deep Learning Model Informs Prostate Cancer Diagnosis at MRI. Radiology. 2023 May;307(4):e222276. http://doi:10.1148/radiol.222276. Epub 2023 Apr 11. PMID: 37039688.
Suarez-Ibarrola R, Sigle A, Eklund M, Eberli D, Miernik A, Benndorf M, Bamberg F, Gratzke C. Artificial Intelligence in Magnetic Resonance Imaging-based Prostate Cancer Diagnosis: Where Do We Stand in 2021? Eur Urol Focus. 2022 Mar;8(2):409-417. http://doi: 10.1016/j.euf.2021.03.020. Epub 2021 Mar 25. PMID: 33773964.
Nagpal K, Foote D, Tan F, Liu Y, Chen PC, Steiner DF, Manoj N, Olson N, Smith JL, Mohtashamian A, Peterson B, Amin MB, Evans AJ, Sweet JW, Cheung C, van der Kwast T, Sangoi AR, Zhou M, Allan R, Humphrey PA, Hipp JD, Gadepalli K, Corrado GS, Peng LH, Stumpe MC, Mermel CH. Development and Validation of a Deep Learning Algorithm for Gleason Grading of Prostate Cancer From Biopsy Specimens. JAMA Oncol. 2020 Sep 1;6(9):1372-1380. http://doi:10.1001/jamaoncol.2020.2485. PMID: 32701148; PMCID: PMC7378872.
Lokhande A, Bonthu S, Singhal N. Carcino-Net: A Deep Learning Framework for Automated Gleason Grading of Prostate Biopsies. Annu Int Conf IEEE Eng Med Biol Soc. 2020 Jul;2020:1380-1383. http://doi:10.1109/EMBC44109.2020.9176235. PMID: 33018246.
Bulten W, Pinckaers H, van Boven H, Vink R, de Bel T, van Ginneken B, van der Laak J, Hulsbergen-van de Kaa C, Litjens G. Automated deep-learning system for Gleason grading of prostate cancer using biopsies: a diagnostic study. Lancet Oncol. 2020 Feb;21(2):233-241. http://doi:10.1016/S1470-2045(19)30739-9. Epub 2020 Jan 8. PMID: 31926805.
Bulten W, Balkenhol M, Belinga JA, Brilhante A, Çakır A, Egevad L, Eklund M, Farré X, Geronatsiou K, Molinié V, Pereira G, Roy P, Saile G, Salles P, Schaafsma E, Tschui J, Vos AM; ISUP Pathology Imagebase Expert Panel; van Boven H, Vink R, van der Laak J, Hulsbergen-van der Kaa C, Litjens G. Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists. Mod Pathol. 2021 Mar;34(3):660-671. http://doi:10.1038/s41379-020-0640-y. Epub 2020 Aug 5. PMID: 32759979; PMCID: PMC7897578.
Gravina M, Spirito L, Celentano G, Capece M, Creta M, Califano G, Collà Ruvolo C, Morra S, Imbriaco M, Di Bello F, Sciuto A, Cuocolo R, Napolitano L, La Rocca R, Mirone V, Sansone C, Longo N. Machine Learning and Clinical-Radiological Characteristics for the Classification of Prostate Cancer in PI-RADS 3 Lesions. Diagnostics (Basel). 2022 Jun 28;12(7):1565. http://doi:10.3390/diagnostics12071565. PMID: 35885471; PMCID: PMC9323238.
Jin P, Shen J, Yang L, Zhang J, Shen A, Bao J, Wang X. Machine learning-based radiomics model to predict benign and malignant PI-RADS v2.1 category 3 lesions: a retrospective multi-center study. BMC Med Imaging. 2023 Mar 29;23(1):47. http://doi: 10.1186/s12880-023-01002-9. PMID: 36991347; PMCID: PMC10053087.
Schrader A, Netzer N, Hielscher T, Görtz M, Zhang KS, Schütz V, Stenzinger A, Hohenfellner M, Schlemmer HP, Bonekamp D. Prostate cancer risk assessment and avoidance of prostate biopsies using fully automatic deep learning in prostate MRI: comparison to PI-RADS and integration with clinical data in nomograms. Eur Radiol. 2024 Dec;34(12):7909-7920. http://doi:10.1007/s00330-024-10818-0. Epub 2024 Jul 2. PMID: 38955845; PMCID: PMC11557625.
Knudsen JE, Ghaffar U, Ma R, Hung AJ. Clinical applications of artificial intelligence in robotic surgery. J Robot Surg. 2024 Mar 1;18(1):102. http://doi:10.1007/s11701-024-01867-0. PMID: 38427094; PMCID: PMC10907451.
Hasannejadasl H, Osong B, Bermejo I, van der Poel H, Vanneste B, van Roermund J, Aben K, Zhang Z, Kiemeney L, Van Oort I, Verwey R, Hochstenbach L, Bloemen E, Dekker A, Fijten RRR. A comparison of machine learning models for predicting urinary incontinence in men with localized prostate cancer. Front Oncol. 2023 Apr 12;13:1168219. http://doi:10.3389/fonc.2023.1168219. PMID: 37124522; PMCID: PMC10130634.
Yucetas U, Aglamis E, Ates HA, Behzatoglu K, Erkan E, Toktas MG, Unluer E. Is cystoscopy follow-up protocol safe for low-risk bladder cancer without muscle invasion? Urol Ann. 2020 Jan-Mar;12(1):25-30. http://doi:10.4103/UA.UA_143_18. Epub 2019 Nov 7. PMID: 32015613; PMCID: PMC6978980.
Yoo JW, Koo KC, Chung BH, Baek SY, Lee SJ, Park KH, Lee KS. Deep learning diagnostics for bladder tumor identification and grade prediction using RGB method. Sci Rep. 2022 Oct 21;12(1):17699. http://doi:10.1038/s41598-022-22797-7. PMID: 36271252; PMCID: PMC9587038.
Chauhan PS, Shiang A, Alahi I, Sundby RT, Feng W, Gungoren B, Nawaf C, Chen K, Babbra RK, Harris PK, Qaium F, Hatscher C, Antiporda A, Brunt L, Mayer LR, Shern JF, Baumann BC, Kim EH, Reimers MA, Smith ZL, Chaudhuri AA. Urine cell-free DNA multi-omics to detect MRD and predict survival in bladder cancer patients. NPJ Precis Oncol. 2023 Jan 19;7(1):6. http://doi:10.1038/s41698-022-00345-w. PMID: 36658307; PMCID: PMC9852243.
Jobczyk M, Stawiski K, Kaszkowiak M, Rajwa P, Różański W, Soria F, Shariat SF, Fendler W. Deep Learning-based Recalibration of the CUETO and EORTC Prediction Tools for Recurrence and Progression of Non-muscle-invasive Bladder Cancer. Eur Urol Oncol. 2022 Feb;5(1):109-112. http://doi:10.1016/j.euo.2021.05.006. Epub 2021 Jun 3. PMID: 34092528.
Tokuyama N, Saito A, Muraoka R, Matsubara S, Hashimoto T, Satake N, Matsubayashi J, Nagao T, Mirza AH, Graf HP, Cosatto E, Wu CL, Kuroda M, Ohno Y. Prediction of non-muscle invasive bladder cancer recurrence using machine learning of quantitative nuclear features. Mod Pathol. 2022 Apr;35(4):533-538. http://doi:10.1038/s41379-021-00955-y. Epub 2021 Oct 29. PMID: 34716417; PMCID: PMC8964412.
Qin Y, Zu X, Li Y, Han Y, Tan J, Cai C, Shen E, Liu P, Deng G, Feng Z, Wu W, Peng Y, Liu Y, Ma J, Zeng S, Chen Y, Shen H. A cancer-associated fibroblast subtypes-based signature enables the evaluation of immunotherapy response and prognosis in bladder cancer. iScience. 2023 Aug 25;26(9):107722. http://doi:10.1016/j.isci.2023.107722. PMID: 37694141; PMCID: PMC10485638.
Baek SW, Leem SH. A Multi-Gene Signature of Non-Muscle-Invasive Bladder Cancer Identifies Patients Who Respond to Immunotherapies Including Bacillus Calmette-Guérin and Immune Checkpoint Inhibitors. Int J Mol Sci. 2024 Mar 28;25(7):3800. http://doi: 10.3390/ijms25073800. PMID: 38612609; PMCID: PMC11012101.
Ren S, Lu Y, Zhang G, Xie K, Chen D, Cai X, Ye M. Integration of Graph Neural Networks and multi-omics analysis identify the predictive factor and key gene for immunotherapy response and prognosis of bladder cancer. J Transl Med. 2024 Dec 23;22(1):1141. http://doi:10.1186/s12967-024-05976-0. PMID: 39716185; PMCID: PMC11664855.
Wentland AL, Yamashita R, Kino A, Pandit P, Shen L, Brooke Jeffrey R, Rubin D, Kamaya A. Differentiation of benign from malignant solid renal lesions using CT-based radiomics and machine learning: comparison with radiologist interpretation. Abdom Radiol (NY). 2023 Feb;48(2):642-648. http://doi:10.1007/s00261-022-03735-7. Epub 2022 Nov 12. PMID: 36370180.
Jiwani R, Pal K, Paolucci I, Odisio B, Brock K, Tannir NM, Shapiro DD, Msaouel P, Sheth RA. Differentiating between renal medullary and clear cell renal carcinoma with a machine learning radiomics approach. Oncologist. 2025 Feb 6;30(2):oyae337. http://doi: 10.1093/oncolo/oyae337. PMID: 39963829; PMCID: PMC11833245.
Shankar V, Vijayalakshmi K, Nolley R, Sonn GA, Kao CS, Zhao H, Wen R, Eberlin LS, Tibshirani R, Zare RN, Brooks JD. Distinguishing Renal Cell Carcinoma From Normal Kidney Tissue Using Mass Spectrometry Imaging Combined With Machine Learning. JCO Precis Oncol. 2023 Jun;7:e2200668. http://doi:10.1200/PO.22.00668. PMID: 37285559; PMCID: PMC10309512.
Suarez-Ibarrola R, Basulto-Martinez M, Heinze A, Gratzke C, Miernik A. Radiomics Applications in Renal Tumor Assessment: A Comprehensive Review of the Literature. Cancers (Basel). 2020 May 28;12(6):1387. http://doi:10.3390/cancers12061387. PMID: 32481542; PMCID: PMC7352711.
Ferro M, Crocetto F, Barone B, Del Giudice F, Maggi M, Lucarelli G, Busetto GM, Autorino R, Marchioni M, Cantiello F, Crocerossa F, Luzzago S, Piccinelli M, Mistretta FA, Tozzi M, Schips L, Falagario UG, Veccia A, Vartolomei MD, Musi G, de Cobelli O, Montanari E, Tătaru OS. Artificial intelligence and radiomics in evaluation of kidney lesions: a comprehensive literature review. Ther Adv Urol. 2023 Apr 17;15:17562872231164803. http://doi:10.1177/17562872231164803. PMID: 37113657; PMCID: PMC10126666.
Kan HC, Lin PH, Shao IH, Cheng SC, Fan TY, Chang YH, Huang LK, Chu YC, Yu KJ, Chuang CK, Wu CT, Pang ST, Peng SJ. Using deep learning to differentiate among histology renal tumor types in computed tomography scans. BMC Med Imaging. 2025 Feb 26;25(1):66. http://doi:10.1186/s12880-025-01606-3. PMID: 40011809; PMCID: PMC11866614.
Yang H, Wu K, Liu H, Wu P, Yuan Y, Wang L, Liu Y, Zeng H, Li J, Liu W, Wu S. An automated surgical decision-making framework for partial or radical nephrectomy based on 3D-CT multi-level anatomical features in renal cell carcinoma. Eur Radiol. 2023 Nov;33(11):7532-7541. http://doi:10.1007/s00330-023-09812-9. Epub 2023 Jun 8. PMID: 37289245; PMCID: PMC10598088.
Wood AM, Abdallah N, Heller N, Benidir T, Isensee F, Tejpaul R, Suk-Ouichai C, Curry C, You A, Remer E, Haywood S, Campbell S, Papanikolopoulos N, Weight C. Fully Automated Versions of Clinically Validated Nephrometry Scores Demonstrate Superior Predictive Utility versus Human Scores. BJU Int. 2024 Jun;133(6):690-698. http://doi: 10.1111/bju.16276. Epub 2024 Feb 11. PMID: 38343198; PMCID: PMC11185291.
Zuluaga L, Rich JM, Gupta R, Pedraza A, Ucpinar B, Okhawere KE, Saini I, Dwivedi P, Patel D, Zaytoun O, Menon M, Tewari A, Badani KK. AI-powered real-time annotations during urologic surgery: The future of training and quality metrics. Urol Oncol. 2024 Mar;42(3):57-66. http://doi:10.1016/j.urolonc.2023.11.002. Epub 2023 Dec 22. PMID: 38142209.
Bogar PZ, Virag M, Bene M, Hardi P, Matuz A, Schlegl AT, Toth L, Molnar F, Nagy B, Rendeki S, Berner-Juhos K, Ferencz A, Fischer K, Maroti P. Validation of a novel, low-fidelity virtual reality simulator and an artificial intelligence assessment approach for peg transfer laparoscopic training. Sci Rep. 2024 Jul 19;14(1):16702. http://doi:10.1038/s41598-024-67435-6. PMID: 39030307; PMCID: PMC11271545.
.Belmar F, Gaete MI, Escalona G, Carnier M, Durán V, Villagrán I, Asbun D, Cortés M, Neyem A, Crovari F, Alseidi A, Varas J. Artificial intelligence in laparoscopic simulation: a promising future for large-scale automated evaluations. Surg Endosc. 2023 Jun;37(6):4942-4946. http://doi:10.1007/s00464-022-09576-1. Epub 2022 Oct 3. PMID: 36192656; PMCID: PMC9529161.
Brian, R., Murillo, A., Gomes, C. et al. Artificial intelligence and robotic surgical education.Global Surg Educ 3, 60 (2024). https://doi.org/10.1007/s44186-024-00262-5
Zhang L, Zhang X, Pu Y, Zhang Y, Fan J. Global, Regional, and National Burden of Urolithiasis from 1990 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019. Clin Epidemiol. 2022 Aug 15;14:971-983. http://doi:10.2147/CLEP.S370591. PMID: 35996396; PMCID: PMC9391934.
Pathan SA, Mitra B, Bhutta ZA, Qureshi I, Spencer E, Hameed AA, Nadeem S, Tahir R, Anjum S, Cameron PA. A comparative, epidemiological study of acute renal colic presentations to emergency departments in Doha, Qatar, and Melbourne, Australia. Int J Emerg Med. 2018 Jan 3;11(1):1. http://doi:10.1186/s12245-017-0160-9. PMID: 29299773; PMCID: PMC5752646.
Elton DC, Turkbey EB, Pickhardt PJ, Summers RM. A deep learning system for automated kidney stone detection and volumetric segmentation on noncontrast CT scans. Med Phys. 2022 Apr;49(4):2545-2554. http://doi:10.1002/mp.15518. Epub 2022 Feb 22. PMID: 35156216; PMCID: PMC10407943.
Mayya AM, Alkayem NF. A Novel Ensemble Learning Approach for Grouping the State-of-the-Art YOLOV10 and YOLOV11 Models for Kidney Stone Detection in CT and Ultrasound Images. J Imaging Inform Med. 2025 Apr 15. http://doi:10.1007/s10278-025-01499-2. Epub ahead of print. Erratum in: J Imaging Inform Med. 2025 Jun 25. doi: 10.1007/s10278-025-01568-6. PMID: 40234345.
Tsai MC, Lu HH, Chang YC, Huang YC, Fu LS. Automatic Screening of Pediatric Renal Ultrasound Abnormalities: Deep Learning and Transfer Learning Approach. JMIR Med Inform. 2022 Nov 2;10(11):e40878. http://doi:10.2196/40878. PMID: 36322109; PMCID: PMC9669887.
Schönthaler M, Miernik A. Bildgebung bei Urolithiasis [Imaging for urolithiasis]. Urologie. 2023 Nov;62(11):1144-1152. German. http://doi:10.1007/s00120-023-02193-3. Epub 2023 Sep 13. PMID: 37702750.
De Perrot T, Hofmeister J, Burgermeister S, Martin SP, Feutry G, Klein J, Montet X. Differentiating kidney stones from phleboliths in unenhanced low-dose computed tomography using radiomics and machine learning. Eur Radiol. 2019 Sep;29(9):4776-4782. http://doi:10.1007/s00330-019-6004-7. Epub 2019 Feb 12. PMID: 30747299.
Yildirim K, Bozdag PG, Talo M, Yildirim O, Karabatak M, Acharya UR. Deep learning model for automated kidney stone detection using coronal CT images. Comput Biol Med. 2021 Aug;135:104569. http://doi:10.1016/j.compbiomed.2021.104569. Epub 2021 Jun 14. PMID: 34157470.
Kim US, Kwon HS, Yang W, Lee W, Choi C, Kim JK, Lee SH, Rim D, Han JH. Prediction of the composition of urinary stones using deep learning. Investig Clin Urol. 2022 Jul;63(4):441-447. http://doi:10.4111/icu.20220062. Epub 2022 May 25. PMID: 35670006; PMCID: PMC9262483.
Chen CW, Liu WY, Huang LY, Chu YW. Using ensemble learning and hierarchical strategy to predict the outcomes of ESWL for upper ureteral stone treatment. Comput Biol Med. 2024 Sep;179:108904. http://doi:10.1016/j.compbiomed.2024.108904. Epub 2024 Jul 23. PMID: 39047504.
Zou XC, Luo CW, Yuan RM, Jin MN, Zeng T, Chao HC. Develop a radiomics-based machine learning model to predict the stone-free rate post-percutaneous nephrolithotomy. Urolithiasis. 2024 Apr 13;52(1):64. http://doi:10.1007/s00240-024-01562-7. PMID: 38613668.
El-Nahas AR. Editorial Comment on: Predicting the Postoperative Outcome of Percutaneous Nephrolithotomy with Machine Learning System: Software Validation and Comparative Analysis with Guy's Stone Score and the CROES Nomogram by Aminsharifi et al. (J Endourol 2020;34(6):692-699; DOI: 10.1089/end.2019.0475). J Endourol. 2020 Jun;34(6):699-700. http://doi:10.1089/end.2020.0203. Epub 2020 Apr 21. PMID: 32204611.
Lee HJ, Aslim EJ, Balamurali BT, Ng LYS, Kuo TLC, Lin CMY, Clarke CJ, Priyadarshinee P, Chen JM, Ng LG. Development and Validation of a Deep Learning System for Sound-based Prediction of Urinary Flow. Eur Urol Focus. 2023 Jan;9(1):209-215. http://doi:10.1016/j.euf.2022.06.011. Epub 2022 Jul 11. PMID: 35835694.
Bang S, Tukhtaev S, Ko KJ, Han DH, Baek M, Jeon HG, Cho BH, Lee KS. Feasibility of a deep learning-based diagnostic platform to evaluate lower urinary tract disorders in men using simple uroflowmetry. Investig Clin Urol. 2022 May;63(3):301-308. http://doi: 10.4111/icu.20210434. Epub 2022 Mar 25. PMID: 35437961; PMCID: PMC9091823.
Shin H, Ko KJ, Park WJ, Han DH, Yeom I, Lee KS. Machine Learning Models for the Noninvasive Diagnosis of Bladder Outlet Obstruction and Detrusor Underactivity in Men With Lower Urinary Tract Symptoms. Int Neurourol J. 2024 Nov;28(Suppl 2):S74-81. http://doi:10.5213/inj.2448360.180. Epub 2024 Nov 30. PMID: 39638454; PMCID: PMC11627226.
Jin J, Chung Y, Kim W, Heo Y, Jeon J, Hoh J, Park J, Jo J. Classification of Bladder Emptying Patterns by LSTM Neural Network Trained Using Acoustic Signatures. Sensors (Basel). 2021 Aug 6;21(16):5328. http://doi:10.3390/s21165328. PMID: 34450769; PMCID: PMC8400043.
Gori D, Banerjee I, Chung BI, Ferrari M, Rucci P, Blayney DW, Brooks JD, Hernandez-Boussard T. Extracting Patient-Centered Outcomes from Clinical Notes in Electronic Health Records: Assessment of Urinary Incontinence After Radical Prostatectomy. EGEMS (Wash DC). 2019 Aug 20;7(1):43. http://doi:10.5334/egems.297. PMID: 31497615; PMCID: PMC6706996.
Rahman SN, Monaghan TF, Weiss JP. Development and Validation of a Machine Learning Algorithm for Predicting Response to Anticholinergic Medications for Overactive Bladder Syndrome. Obstet Gynecol. 2020 Feb;135(2):483. http://doi: 10.1097/AOG.0000000000003687. PMID: 31977788.
Werneburg GT, Werneburg EA, Goldman HB, Mullhaupt AP, Vasavada SP. Machine learning provides an accurate prognostication model for refractory overactive bladder treatment response and is noninferior to human experts. Neurourol Urodyn. 2022 Mar;41(3):813-819. http://doi:10.1002/nau.24881. Epub 2022 Jan 25. PMID: 35078268.
Werneburg GT, Werneburg EA, Goldman HB, Mullhaupt AP, Vasavada SP. Neural networks outperform expert humans in predicting patient impressions of symptomatic improvement following overactive bladder treatment. Int Urogynecol J. 2023 May;34(5):1009-1016. http://doi:10.1007/s00192-022-05291-6. Epub 2022 Jul 26. PMID: 35881179.
Gravas S, Chasiotis G, Gacci M, Calik G, Liaci A, Dellis A, Sountoulides P, Laguna MP, DE LA Rosette J. The feasibility and acceptability of a (mobile) application for men with lower urinary tract symptoms: a pilot study. Minerva Urol Nephrol. 2025 Jun 27. http://doi: 10.23736/S2724-6051.25.06352-9. Epub ahead of print. PMID: 40576949.
Lee K, Lee MH, Kang D, Kim S, Chang JH, Oh SJ, Hwang JY. Intelligent Bladder Volume Monitoring for Wearable Ultrasound Devices: Enhancing Accuracy Through Deep Learning-Based Coarse-to-Fine Shape Estimation. IEEE Trans Ultrason Ferroelectr Freq Control. 2024 Jul;71(7):775-785. http://doi:10.1109/TUFFC.2024.3350033. Epub 2024 Jul 9. PMID: 38190679.
Verma R, Macaskill F, Kim A, Raison N, Dasgupta P. Ethical aspects of artificial intelligence: what urologists need to know. Curr Opin Urol. 2025 May 1;35(3):224-229. doi: 10.1097/MOU.0000000000001278. Epub 2025 Mar 20. PMID: 40114646; PMCID: PMC11970583.
Pham T. Ethical and legal considerations in healthcare AI: innovation and policy for safe and fair use. R Soc Open Sci. 2025 May 14;12(5):241873. http://doi:10.1098/rsos.241873. PMID: 40370601; PMCID: PMC12076083.
van Kolfschooten HB. A health-conformant reading of the GDPR's right not to be subject to automated decision-making. Med Law Rev. 2024 Aug 1;32(3):373-391. http://doi: 10.1093/medlaw/fwae029. PMID: 39135367; PMCID: PMC11347939.
Naik BN, Sujith J, Kajal K. Maffucci syndrome and anaesthesia: Case report. Indian J Anaesth. 2019 May;63(5):400-402. http://doi:10.4103/ija.IJA_779_18. PMID: 31142885; PMCID: PMC6530275.
Chen C, Chen X, Chen J, Xing J, Hei Z, Zhang Q, Liu Z, Zhou S. Association between Preoperative hs-crp/Albumin Ratio and Postoperative sirs in Elderly Patients: A Retrospective Observational Cohort Study. J Nutr Health Aging. 2022;26(4):352-359.http://doi:10.1007/s12603-022-1761-4. PMID: 35450991.
Kelly CJ, Karthikesalingam A, Suleyman M, Corrado G, King D. Key challenges for delivering clinical impact with artificial intelligence. BMC Med. 2019 Oct 29;17(1):195. http://doi:10.1186/s12916-019-1426-2. PMID: 31665002; PMCID: PMC6821018.
Voets MM, Veltman J, Slump CH, Siesling S, Koffijberg H. Systematic Review of Health Economic Evaluations Focused on Artificial Intelligence in Healthcare: The Tortoise and the Cheetah. Value Health. 2022 Mar;25(3):340-349. http://doi:10.1016/j.jval.2021.11.1362. Epub 2021 Dec 16. PMID: 35227444.
Downloads
Published
Issue
Section
License
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.

